Found: 9
Select item for more details and to access through your institution.
Design and Selection of Toca 511 for Clinical Use: Modified Retroviral Replicating Vector With Improved Stability and Gene Expression.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 9, p. 1689, doi. 10.1038/mt.2012.83
- By:
- Publication type:
- Article
Toca 511 gene transfer and treatment with the prodrug, 5-fluorocytosine, promotes durable antitumor immunity in a mouse glioma model.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 7, p. 930, doi. 10.1093/neuonc/nox037
- By:
- Publication type:
- Article
Retroviral replicating vector-mediated gene therapy achieves long-term control of tumor recurrence and leads to durable anticancer immunity.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 7, p. 918, doi. 10.1093/neuonc/nox038
- By:
- Publication type:
- Article
Toca 511 plus 5-fluorocytosine in combination with lomustine shows chemotoxic and immunotherapeutic activity with no additive toxicity in rodent glioblastoma models.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 10, p. 1390, doi. 10.1093/neuonc/now089
- By:
- Publication type:
- Article
Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 2, p. 145, doi. 10.1093/neuonc/nor199
- By:
- Publication type:
- Article
Carotid Body Paraganglioma Regression with Relief of Hypoxemia.
- Published in:
- Annals of Internal Medicine, 1980, v. 92, n. 6, p. 800, doi. 10.7326/0003-4819-92-6-800
- By:
- Publication type:
- Article
Inhibition by AICA riboside of gluconeogenesis in isolated rat hepatocytes.
- Published in:
- 1991
- By:
- Publication type:
- journal article
AICA-Riboside: Safety, Tolerance, and Pharmacokinetics of a Novel Adenosine-Regulating Agent.
- Published in:
- 1991
- By:
- Publication type:
- Other
CADD-23. PD-L1 CHECKPOINT BLOCKADE USING A SINGLE-CHAIN VARIABLE FRAGMENT TARGETING PD-L1 DELIVERED BY RETROVIRAL REPLICATING VECTOR (TOCA 521) ENHANCES ANTI-TUMOR EFFECT IN CANCER MODELS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi280, doi. 10.1093/neuonc/noy148.1166
- By:
- Publication type:
- Article